Anzeige
Mehr »
Sonntag, 22.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
984 Leser
Artikel bewerten:
(2)

Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s securities were suspended on July 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Financial Strategies Acquisition Corp. Financial Strategies Acquisition Corp.'s securities were suspended on August 31, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Kiromic BioPharma, Inc. Kiromic BioPharma, Inc.'s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.'s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Molekule Group, Inc. Molekule Group, Inc.'s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of EBET, Inc. EBET, Inc.'s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Shift Technologies, Inc. Shift Technologies, Inc.'s securities were suspended on October 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the preferred stock of Ontrak, Inc. Ontrak, Inc.'s securities were suspended on October 20, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RVL Pharmaceuticals plc. RVL Pharmaceuticals plc's securities were suspended on October 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Biocept, Inc. Biocept, Inc.'s securities were suspended on October 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Akumin Inc. Akumin Inc.'s securities were suspended on October 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Appreciate Holdings, Inc. Appreciate Holdings, Inc.'s securities were suspended on October 27, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Liberty TripAdvisor Holdings, Inc. Liberty TripAdvisor Holdings, Inc.'s securities were suspended on October 30, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Tempo Automation Holdings, Inc. Tempo Automation Holdings, Inc.'s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Medicenna Therapeutics Corp. Medicenna Therapeutics Corp.'s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RiceBran Technologies. RiceBran Technologies's securities were suspended on November 8, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Acer Therapeutics Inc. Acer Therapeutics Inc.'s securities were suspended on November 9, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Energiepreisschock - Diese 3 Werte könnten langfristig abräumen!
Die Eskalation im Iran-Konflikt hat die Energiepreise mit voller Wucht nach oben getrieben. Was zunächst nach einer kurzfristigen Reaktion aussah, entwickelt sich zunehmend zu einem strukturellen Problem: Die Straße von Hormus ist blockiert, wichtige LNG- und Ölanlagen stehen still oder werden gezielt angegriffen. Eine schnelle Entspannung ist nicht in Sicht – im Gegenteil, die Lage spitzt sich weiter zu.

Für die Weltwirtschaft bedeutet dies wachsende Risiken. Steigende Energiepreise erhöhen den Inflationsdruck, gefährden Zinssenkungen und bringen die ohnehin hoch bewerteten Aktienmärkte ins Wanken. Doch wo Risiken entstehen, ergeben sich auch Chancen.

Denn von einem dauerhaft höheren Energiepreisniveau profitieren nicht nur Öl- und Gasunternehmen. Auch Versorger, erneuerbare Energien sowie ausgewählte Rohstoff- und Agrarwerte rücken in den Fokus. In diesem Umfeld könnten gezielt ausgewählte Unternehmen überdurchschnittlich profitieren – unabhängig davon, ob die Krise anhält oder nicht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die genau dieses Profil erfüllen: Krisenprofiteure mit solidem Geschäftsmodell, attraktiver Bewertung und langfristigem Potenzial.

Jetzt den kostenlosen Report sichern – und Ihr Depot auf den Energiepreisschock vorbereiten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.